Wuhan Easy Diagnosis Biomedicine Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 24.96% vs -1.00% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -291.00% vs 394.12% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "86.60",
          "val2": "69.30",
          "chgp": "24.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-55.20",
          "val2": "-17.30",
          "chgp": "-219.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.10",
          "val2": "10.00",
          "chgp": "-291.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-636.90%",
          "val2": "-489.70%",
          "chgp": "-14.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -53.20% vs -92.86% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -61.56% vs -98.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "349.70",
          "val2": "747.30",
          "chgp": "-53.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-70.70",
          "val2": "92.40",
          "chgp": "-176.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "10.80",
          "chgp": "-86.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-16.50",
          "val2": "-37.20",
          "chgp": "55.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.60",
          "val2": "69.20",
          "chgp": "-61.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-423.70%",
          "val2": "-3.70%",
          "chgp": "-42.00%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

86.60

69.30

24.96%

Operating Profit (PBDIT) excl Other Income

-55.20

-17.30

-219.08%

Interest

0.10

0.00

Exceptional Items

0.00

-1.10

100.00%

Consolidate Net Profit

-19.10

10.00

-291.00%

Operating Profit Margin (Excl OI)

-636.90%

-489.70%

-14.72%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 24.96% vs -1.00% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -291.00% vs 394.12% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

349.70

747.30

-53.20%

Operating Profit (PBDIT) excl Other Income

-70.70

92.40

-176.52%

Interest

1.50

10.80

-86.11%

Exceptional Items

-16.50

-37.20

55.65%

Consolidate Net Profit

26.60

69.20

-61.56%

Operating Profit Margin (Excl OI)

-423.70%

-3.70%

-42.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -53.20% vs -92.86% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -61.56% vs -98.42% in Dec 2023

All Annual Results